Screener
Eligibility screening
Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
2 US sites in MI, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.